|Comments from Faculty and Members
David Elpern MD, Dermatologist, Williamstown, MA,
USA on Aug 6, 2007
Imiquimod may be a viable option for the more superficial lesions.
Graceway Pharmaceuticals will give you samples for this man.
No one should be left unattended because of coverage -- but
this is common -- much more so in the USA than Canada where
this man lives.
Bushan Kumar MD, Former Professor of Dermatology, PGIMER,
Chandigarh, India on Aug 6, 2007
I would use imiquimod twice a day - 4 days a week combined
Khaled el-hoshy MD, Troy, Michigan, USA on
August 7, 2007
5 FU would be my 1st choice. Weekend only applications to decrease
inflammatory reaction. Evaluate every 2-3 months. another option
is medium depth peel. Sunscreens an absolute must.
Haitham Alqari MD, Consultant dermatologist, Arabian
Gulf University, SMC, Kingdom of Bahrain on August
Typical scenario of Albino with tendency to develop BCCs and/or
SCCs. I think he will benefit from topical imiquimod application.
R/O Basal cell nevus syndrome, although such syndrome present
earlier in life with predilection to the back and characterized
by five major components, including multiple nevoid basal cell
carcinomas, jaw cysts, congenital skeletal abnormalities, ectopic
calcifications, and plantar or palmar pits.
Khalifa Sharquie MD, Professor of Dermatology, College
of Medicine, University of Baghdad, Baghdad, Iraq on
August 8, 2007
We have large experience with zinc sulfate for the last 15
years in treatment of BCC either intralesional injection 2%
zinc sulfate sol in distilled water evey 2 weeks until clearance
with or without topical 20% topical zinc sulfate twice a day.
It is an effective encouraging treatment with very nice cosmetic
Ref: Sharquie KE, Al-Nuaimy AA, Al-Shimary FA. New intralesional
therapy for basal cell carcinoma by 2% zinc sulphate solution.
Saudi Med J. 2005 Feb;26(2):359-61.